BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Metabolism of xenobiotics, Pseudomonas infection, Embryo, Nosology, Rosiglitazone)
Bookmark Forward

QuickView for D1 receptor (gene)


Body Atlas

Most Correlated Tissues

  1. Putamen
  2. Accumbens
  3. Caudate nucleus
  4. Caudate
  5. Superior cervical ganglion
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Huntington's disease
  2. Ischemic reperfusion injury
  3. Radiation injury
  4. Nerve injury
  5. Disorder of basal ganglia
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. acetophenazine
  2. Dopamine
  3. Lisuride
  4. Methylergonovine
  5. Fenoldopam
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR21
  2. Mir30b
  3. MIRLET7D
  4. SORD
  5. CDK7
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. The role of the dopamine D1 receptor in anticipatory pleasure and social play.
  2. Loss-of-Function Variants in DRD1 in Infantile Parkinsonism-Dystonia.
  3. Acute manipulation of Drd1 neurons in the prefrontal cortex bidirectionally regulates anxiety and de…
  4. Single-cell RNA-seq Reveals the Inhibitory Effect of Methamphetamine on Liver Immunity with the Invo…
  5. The selective dopamine D1 receptor agonist SKF81297 modulates NMDA receptor currents independently o…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562
  2. Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects
  3. D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement
  4. A Study To Evaluate D1 Receptor Occupancy (RO) Following Single Dose of PF-06412562 In Healthy Male …
  5. Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.